CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study.

Weinblatt, M E; Maddison, P J; Bulpitt, K J; Hazleman, B L; Urowitz, M B; Sturrock, R D; Coblyn, J S; Maier, A L; Spreen, W R; Manna, V K

Weinblatt, M E; Maddison, P J; Bulpitt, K J; Hazleman, B L; Urowitz, M B; Sturrock, R D; Coblyn, J S; Maier, A L; Spreen, W R; Manna, V K.

Affiliation

Weinblatt ME; Department of Rheumatology and Immunology, Brigham and Women's Hospital, USA.

Arthritis Rheum ; 38(11): 1589-94, 1995 Nov.

Article in En | MEDLINE | ID: mdl-7488279

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/immunology; Antibodies, Neoplasm; Arthritis, Rheumatoid/therapy; Adult; Alemtuzumab; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Cohort Studies; Dose-Response Relationship, Immunologic; Drug Tolerance; Humans; Injections, Intravenous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antibodies, Monoclonal / Antibodies, Neoplasm Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Arthritis Rheum Year: 1995 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links